What problem does this paper attempt to address?

The main problem that this paper attempts to solve is to develop a new method to create heterologous host bacteria (i.e., bacteria that do not naturally produce a certain antibiotic) to produce antibiotics that are lethally toxic to the host bacteria. Specifically, the research team aims to overcome the toxicity problem of antibiotics to host bacteria by screening combinatorial libraries and optimizing the selection of promoters, thereby successfully creating heterologous host bacteria capable of efficiently producing lethal antibiotics. ### Research Background and Problems 1. **Antibiotic Resistance Problem**: With the increase in antibiotic resistance, the discovery of new antibiotics has become particularly urgent. However, many potential antibiotics are toxic to host bacteria when expressed in vivo, resulting in the inability to effectively produce these antibiotics. 2. **Heterologous Expression Challenges**: When host bacteria do not have resistance to antibiotics, they will be killed during the production process, and thus valuable antibiotic products cannot be obtained. 3. **Limitations of Existing Technologies**: Traditional gene cluster transfer methods are difficult to achieve efficient antibiotic production, especially when antibiotics are toxic to the host. ### Solutions To overcome the above challenges, the research team proposed the following solutions: - **Constructing Combinatorial Libraries**: Using the Combi - OGAB technology (Combinatorial Ordered Gene Assembly in Bacillus subtilis), a combinatorial library containing multiple promoters was constructed. - **Screening for Optimal Promoters**: Through multiple rounds of screening, the best promoter combinations that can initiate the expression of antibiotic genes at the appropriate growth stage were found, thereby achieving efficient production of antibiotics. - **Optimizing the Expression Timing**: By selecting promoters that are dependent on different growth stages, fine - regulation of the biosynthesis process was achieved, ensuring that antibiotics are produced at the stage when the host bacteria can best tolerate them. ### Experimental Design and Results 1. **Promoter Selection**: Ten promoters that are dependent on different growth stages (divided into four categories) were selected to construct the initial library. 2. **Construction of Combinatorial Libraries**: These ten promoters were inserted upstream of three key genes (grsT, grsA, and grsB) respectively to construct combinatorial libraries. 3. **Screening for High - Yield Strains**: Through multiple rounds of screening, the strain 3rd - C2 with significantly increased productivity was finally obtained, and its antibiotic yield reached approximately 50 times the lethal concentration. ### Conclusions Through this method, the research team successfully created heterologous host bacteria capable of producing antibiotics that are lethally toxic to host bacteria. This achievement provides new ideas for future exploration of new antibiotics from other uncultured bacteria and is expected to promote the progress in the field of antibiotic research and development. ### Explanation of Formulas and Charts The formulas and charts involved in the paper are presented in Markdown format, for example: - The calculation formula for antibiotic yield: \[ \text{Yield}=\frac{\text{Detected antibiotic mass}}{\text{Culture medium volume}} \] - Chart Descriptions: - **Figure 1**: Schematic diagram of the Combi - OGAB screening process. - **Figure 2**: Comparison chart of GS yields driven by different promoters. - **Figure 3**: Chart of changes in GS and by - product yields in four rounds of screening. It is hoped that this information will help you better understand the core content of this paper and the problems it solves. If you have more questions or need further explanations, please feel free to let us know!

A Novel Method for Creating Heterologous Lethal Antibiotic Producers by Screening from Combi-OGAB Library with Various Promoters in a Biosynthetic Gene Cluster

Gene Cluster Analysis for the Biosynthesis of Elgicins, Novel Lantibiotics Produced by Paenibacillus Elgii B69

Novel antibiotic screening methods to awaken silent or cryptic secondary metabolic pathways in actinomycetes

A Novel Nonantibiotic, lgt-Based Selection System for Stable Maintenance of Expression Vectors in Escherichia coli and Vibrio cholerae

Combinatorial biosynthesis of novel aminoglycoside antibiotics via pathway engineering

Engineering Streptomyces coelicolor for heterologous expression of secondary metabolite gene clusters

The Identification and Heterologous Expression of the Biosynthetic Gene Cluster Encoding the Antibiotic and Anticancer Agent Marinomycin

Production of Antimicrobial Compounds by Homologous and Heterologous Expression

An Efficient Procedure For Marker-Free Mutagenesis Of S. Coelicolor By Site-Specific Recombination For Secondary Metabolite Overproduction

An anaerobic bacterium host system for heterologous expression of natural product biosynthetic gene clusters

Development of a native-locus dual reporter system for the efficient screening of the hyper-production of natural products in Streptomyces

Recent advances in activating silent biosynthetic gene clusters in bacteria

Combinatorial metabolic engineering of Bacillus subtilis for de novo production of polymyxin B

Development of a highly efficient base editing system for Lactobacilli to improve probiotics and dissect essential functions

The “Three Cs” of Novel Antibiotic Discovery and Production through Synthetic Biology: Biosynthetic Gene Clusters, Heterologous Chassis, and Synthetic Microbial Consortia

Novel Antibiotic-Free Plasmid Selection System Based on Complementation of Host Auxotrophy in the NAD De Novo Synthesis Pathway

Simple and rapid direct cloning and heterologous expression of natural product biosynthetic gene cluster in Bacillus subtilis via Red/ET recombineering

A streamlined strain engineering workflow with genome-wide screening detects enhanced protein secretion in Komagataella phaffii

Identification and heterologous expression of the globomycin biosynthetic gene cluster

Identification of a novel promoter for driving antibiotic-resistant genes to reduce the metabolic burden during protein expression and effectively select multiple integrations in Pichia Pastoris

Screening Systems for Stable Markerless Genomic Deletions/Integrations in Streptomyces Species